Study Slated to Determine When CLL Patients Should Begin Treatment
Genzyme Genetics, Cambridge, Mass, a nationwide provider of genetic testing and counseling services for physicians and patients, plans to participate in a multi-center Cancer and Leukemia Group B study that will include 1,700 newly diagnosed patients with chronic lymphocytic leukemia.
Read More